REFERENCES
- De Mooerloose P, Reber G, Perrier A, et al. Prevalence of factor V Leiden and prothrombin G20210A mutations in unselected patients with venous thromboembolism. Br J Haematol 2000; 110: 125–129, [CSA]
- Hagstrom J N, Walter J, Bluebond-Langner R, et al. Prevalence of the factor V Leiden mutation in children and neonates with thromboembolic disease. J Pediatr 1998; 133: 777–781, [INFOTRIEVE], [CSA], [CROSSREF]
- Junker R, Novak-Göttle U. The prothrombin G20210A mutation: a common cause of thrombophilia?. J Lab Med 1998; 22: 472–482, [CSA]
- Ocal I T, Sadeghi A, Pres R D. Risk of venous thrombosis in carriers of a common mutation in the homocysteine regulatory enzyme methylenetetrahydrofolate reductase. Mol Diagn 1997; 73: 329–331, [CSA]
- Andrew M, David M, Adams M, et al. Venous thromboembolic complications in children: first analyses of the Canadian registry of VTE. Blood 1994; 83: 1251–1257, [INFOTRIEVE], [CSA]
- Gürgey A, Mesci L, Renda Y, et al. Factor V Q 506 mutation in children with thrombosis. Am J Hematol 1996; 53: 37–39, [CSA], [CROSSREF]
- Novak-Göttle U, Dübbers A, Kececioglu D, et al. Factor V Leiden, protein C, and lipoprotein (a) in catheter-related thrombosis in childhood: a prospective study. J Pediatr 1997; 131: 608–612, [CSA], [CROSSREF]
- Bonduel M, Sciuccati G, Hepner M, et al. Factor V Leiden and prothrombin gene G20210A mutation in children with cerebral thromboembolism. Am J Hematol 2003; 73: 81–86, [INFOTRIEVE], [CSA], [CROSSREF]
- Gürgey A, Unal S, Okur H, et al. Prothrombin G20210A mutation in Turkish children with thrombosis and the frequency of prothrombin C20209T. Pediatr Hematol Oncol 2005; 22: 309–314, [CSA]
- Dunn A S, Kaboli P, Halfdanarson T, et al. Do patients followed in anticoagulation clinics for antiphospholipid syndrome meet criteria for the disorder?. Thromb Haemost 2005; 94: 548–554, [INFOTRIEVE], [CSA]
- Rask O, Berntorp E, Ljung R. Risk factors for venous thrombosis in Swedish children and adolescents. Acta Pediatr 2005; 94: 717–722, [CSA], [CROSSREF]
- Heller C, Becker S, Scharrer I, et al. Prothrombotic risk factors in childhood stroke and venous thrombosis. Eur J Pediatr 1999; 158: S117–5121, [INFOTRIEVE], [CSA], [CROSSREF]
- Junker R, Koch H G, Auberger K, et al. Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia. Arterioscler Thromb Vasc Biol 1999; 19: 2568–2572, [INFOTRIEVE], [CSA]
- Günther G, Junker R, Strater R, et al. Symptomatic ischemic stroke in full-term neonates: role of acquired and genetic prothrombotic risk factors. Stroke 2000; 31: 2437–2441, [CSA]
- Gürgey A, Aslan D. Outcome of noncatheter-related thrombosis in children: influence of underlying or coexisting factors. J Pediatr Hematol Oncol 2001; 23: 159–164, [CSA], [CROSSREF]
- Ören H, Devecioglu O, Ertem M, et al. Analysis of pediatric thrombotic patients in Turkey. Pediatr Hematol Oncol 2004; 21: 573–583, [CSA], [CROSSREF]
- Monagle P, Adams M, Mahoney M, et al. Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry. Pediatr Res 2000; 47: 763–766, [INFOTRIEVE], [CSA]
- Uttenreuther-Fischer M M, Vetter B, Hellmann C, et al. Paediatric thrombo-embolism: the influence of non-genetic factors and the role of activated protein C resistance and protein C deficiency. Eur J Pediatr 1997; 156: 277–281, [INFOTRIEVE], [CSA], [CROSSREF]
- Oran O, Teksam O. Dünyada ve Türkiye'de cocuk sagligive olum nedenleri (Child health in the world and Turkey: the causes of death during childhood). Katki Pediatri Dergisi (In Turkish) 2003; 25: 27–36, [CSA]
- Smith O P. Infectious purpura fulminanas: diagnosis and treatment. Br J Haematol 1999; 104: 202–207, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kirchhofer D, Rieder M A, Baumgartner H R. Specific accumulation of circulating monocytes and polymorphonuclear leukocytes on platelet thrombi in a vascular injury model. Blood 1997; 89: 1270–1280, [INFOTRIEVE], [CSA]
- Gürgey A, Mesci L. The prevalence of factor V leiden (1691 G-A) mutation in Turkey. Turk J Pediatr 1997; 39: 313–315, [CSA]
- Rees D C, Cox M, Clegg J B. World distribution of factor V Leiden. Lancet 1995; 346: 1133–1134, [CSA], [CROSSREF]
- Balta G, Gürgey A. Metylenetetrahydrofolate reduktase (MTHFR) 677 C-T mutation in Turkish patients with thrombosis. Turk J Pediatr 1999; 41: 197–199, [INFOTRIEVE], [CSA]
- Balasa V, Gruppo R A. The relationship of mutation in the MTHFR, prothrombin and Pal-1 genes to the plasma level of homocytein in children and adults. Thromb Haemost 1999; 81: 739–744, [INFOTRIEVE], [CSA]
- Brown K, Luddington R, Baglin T. Efffect of the MTHFR C677T variant on risk of venosus thromboembolism: interaction with factor V Leiden and prothrombin (F2G20210A) mutations. Br J Haematol 1998; 103: 42–44, [INFOTRIEVE], [CSA], [CROSSREF]
- Lane D A, Manucci O M, Bauer K A, et al. Inherited thrombophilia: Part I. Thromb Haemost 1996; 76: 651–662, [INFOTRIEVE], [CSA]
- Frosst P, Bloom H J, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111–113, [INFOTRIEVE], [CSA], [CROSSREF]
- Nowak-Göttle U, Strater R, Heinecke A, et al. Lipoprotein (a) and genetic polymorphism of clotting factor V, prothrombin and methylenetetrahydrofolate reductase are risk factors of ischaemic stroke in childhood. Blood 1999; 94: 3678–3682, [CSA]
- Brown K, Luddington R, Baglin T. Effect of MTHFR C677T variant on risk of venous thromboembolism:interaction with factor V leiden and prothrombin (F2G20210A) mutations. Br J Haematol 1998; 103: 42–44, [INFOTRIEVE], [CSA], [CROSSREF]
- Almawi W Y, Tamim H, Kreidy R, et al. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis. J Thromb Thrombolysis 2005; 19: 189–196, [INFOTRIEVE], [CSA], [CROSSREF]
- Cattaneo M, Tsai M, Bucciarelli P, et al. A common mutation in the methylenetetrahydrofolate reductase gene (C677T) increases the risk for deep vein thrombosis in patients with mutant factor V (factor V:Q506). Arterioscler Thromb Vasc Biol 1997; 17: 1662–1666, [INFOTRIEVE], [CSA]
- Fujimura H, Kawasaki T, Sakata T, et al. Common C677T polymorphism in the methylenetetrahydrofolate reductase gene increase the risk for deep venous vein thrombosis in patients with predisposition of thrombophilia. Thromb Res 2000; 98: 1–8, [INFOTRIEVE], [CSA], [CROSSREF]
- Akar N, Akar E, Akçay R, Avcu F, Yalçin A, Cin S. Effect of methylenetetrahydrofolate reduktase 677 C-T on factor V 1691 mutation in Turkish deep vein thrombosis patients. Thromb Res 2000; 97: 163–167, [INFOTRIEVE], [CSA], [CROSSREF]
- Akar N, Akar E, Misirlioglu M, Avcu F, Yalçin A, Cin S. Search for genetic factors thrombosis in Turkish population. Thromb Res 1998; 79: 79–82, [CSA], [CROSSREF]
- Young G, Manco-Jhonson M, Gill J C, et al. Clinical manifestations of the prothrombin G20210A mutation in children: a pediatric coagulation consortium study. J Thromb Haemost 2003; 1: 1–5, [CSA], [CROSSREF]
- von depka M, Nowak-Gottl U, Eisert R, et al. Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolism. Blood 2000; 96: 3364–3368, [INFOTRIEVE], [CSA]
- Ehrenforth S, Junker R, Koch H G, et al. Multicentre evaluation of combined prothrombotic defects associated with thrombophilia in childhood. Eur J Pediatr 1999; 158(Suppl 3)97–104, [CSA], [CROSSREF]
- Andrew M, Vegh P, Johnston M, et al. Maturation of the hemostatic system during childhood. Blood 1992; 80: 1998–2005, [INFOTRIEVE], [CSA]
- Andrew M. Developmental hemostasis: relevance to thromboembolic complications in pediatric patients. Thromb Haemost 1995; 74: 415–425, [INFOTRIEVE], [CSA]